Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
VRTX

Vertex

$177.12

-8.34 (-4.50%)

11:52
10/18/18
10/18
11:52
10/18/18
11:52
Hot Stocks
Vertex presents data at NACFC demonstrating progress for CF treatment »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

VRTX

Vertex

$178.66

-6.8 (-3.67%)

, PTI

Proteostasis

$7.76

5.87 (310.58%)

11:14
10/18/18
10/18
11:14
10/18/18
11:14
Recommendations
Vertex, Proteostasis analyst commentary at Morgan Stanley »

Vertex weakness on…

VRTX

Vertex

$178.66

-6.8 (-3.67%)

PTI

Proteostasis

$7.76

5.87 (310.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

PTI

Proteostasis

$1.89

-0.01 (-0.53%)

, VRTX

Vertex

$185.46

-0.03 (-0.02%)

07:22
10/18/18
10/18
07:22
10/18/18
07:22
Upgrade
Proteostasis, Vertex rating change at RBC Capital »

Proteostasis upgraded to…

PTI

Proteostasis

$1.89

-0.01 (-0.53%)

VRTX

Vertex

$185.46

-0.03 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

Over a week ago
VRTX

Vertex

$176.41

-9.41 (-5.06%)

, GLPG

Galapagos NV

$97.00

-3.45 (-3.43%)

07:57
10/11/18
10/11
07:57
10/11/18
07:57
Recommendations
Vertex, Galapagos NV analyst commentary at Jefferies »

Jefferies sees shares of…

VRTX

Vertex

$176.41

-9.41 (-5.06%)

GLPG

Galapagos NV

$97.00

-3.45 (-3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

CRSP

Crispr Therapeutics

$36.90

0.05 (0.14%)

, VRTX

Vertex

$177.45

-8.37 (-4.50%)

16:07
10/10/18
10/10
16:07
10/10/18
16:07
Hot Stocks
Crispr Therapeutics, Vertex announce FDA lifts hold for CTX001, accepts IND »

Crispr Therapeutics…

CRSP

Crispr Therapeutics

$36.90

0.05 (0.14%)

VRTX

Vertex

$177.45

-8.37 (-4.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

VRTX

Vertex

$186.22

-2.41 (-1.28%)

13:33
10/05/18
10/05
13:33
10/05/18
13:33
Hot Stocks
CDEC recommends Vertex drug not be reimbursed for treatment of CF »

The CADTH Canadian Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ALNY

Alnylam

$88.16

0.97 (1.11%)

, AMGN

Amgen

$206.87

-0.77 (-0.37%)

09:02
10/04/18
10/04
09:02
10/04/18
09:02
Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Young…

ALNY

Alnylam

$88.16

0.97 (1.11%)

AMGN

Amgen

$206.87

-0.77 (-0.37%)

BMRN

BioMarin

$99.73

0.71 (0.72%)

CELG

Celgene

$91.85

0.01 (0.01%)

GILD

Gilead

$79.01

0.33 (0.42%)

INCY

Incyte

$69.94

0.1 (0.14%)

MYOK

MyoKardia

$60.32

0.11 (0.18%)

PBYI

Puma Biotechnology

$46.40

-0.28 (-0.60%)

PTCT

PTC Therapeutics

$45.27

-0.01 (-0.02%)

REGN

Regeneron

$403.15

2.67 (0.67%)

SRPT

Sarepta

$146.98

4.17 (2.92%)

TSRO

Tesaro

$41.81

1.89 (4.73%)

VRTX

Vertex

$192.24

0.28 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 09

    Nov

  • 27

    Nov

  • 28

    Apr

  • 13

    May

VRTX

Vertex

$192.70

2.97 (1.57%)

08:02
10/01/18
10/01
08:02
10/01/18
08:02
Hot Stocks
Vertex announces access contract in Denmark »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

VRTX

Vertex

$192.70

2.97 (1.57%)

06:01
10/01/18
10/01
06:01
10/01/18
06:01
Initiation
Vertex initiated at Cantor Fitzgerald »

Vertex initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ABBV

AbbVie

$94.50

0.72 (0.77%)

, VRTX

Vertex

$184.11

1.54 (0.84%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Xu,…

ABBV

AbbVie

$94.50

0.72 (0.77%)

VRTX

Vertex

$184.11

1.54 (0.84%)

ACER

Acer Therapeutics

$30.55

(0.00%)

BHVN

Biohaven Pharmaceutical

$37.47

(0.00%)

CELG

Celgene

$88.38

0.82 (0.94%)

EXEL

Exelixis

$17.38

0.19 (1.11%)

PTLA

Portola Pharmaceuticals

$28.27

0.57 (2.06%)

BMY

Bristol-Myers

$62.20

0.38 (0.61%)

BIIB

Biogen

$342.79

1.21 (0.35%)

AMGN

Amgen

$208.06

1.59 (0.77%)

BLUE

Bluebird Bio

$141.90

(0.00%)

ONCE

Spark Therapeutics

$57.63

0.07 (0.12%)

LOXO

Loxo Oncology

$164.55

-2.25 (-1.35%)

RCKT

Rocket Pharmaceuticals

$25.11

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Oct

  • 12

    Oct

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 01

    Dec

  • 31

    Dec

  • 14

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.